The correlation of apolipoprotein B, apolipoprotein B/apolipoprotein A-I ratio and lipoprotein(a) with myocardial infarction

Central European Journal of Medicine

Volumn 3, Issue 4, 2008, Pages 422-429

  Agoston Coldea, Lucia ^a   Mocan, Teodora ^a   Gatfossé, Marc ^b   Dumitrascu, Dan Lucian ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Department of Internal Medicine ^*  (France)

Author keywords

ApoB ApoA I ratio; Apolipoproteins B and A I; Coronary heart disease; Lipoproptein (a)

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; LIPOPROTEIN A;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME CHEMISTRY; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TURBIDIMETRY;

EID: 54449088630     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-008-0057-3     Document Type: Article

References (36)

1. S.M. Grundy D. Becker L.T. Clark R.S. Cooper M.A. Denke J. Howard 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Circulation 106 3143 3421
2. G. De Backer E. Ambrosioni K. Borch-Johnsen C. Brotons R. Cifkova J. Dallongeville 2003 European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Eur. Heart J. 24 1601 1610
3. S.M. Grundy J.I. Cleeman N.B. Merz H.B. Brewer L.T. Clark B.D. Hunninghake 2004 Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation 110 227 293
4. B. Lamarche S. Moorjani P.J. Lupien B. Cantin P.M. Bernard G.R. Dagenais 1996 Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a 5-year follow-up of men in the Quebec Cardiovascular Study Circulation 94 273 278
5. C. Vedhachalam P.T. Duong M. Nickel D. Nguyen P. Dhanasekaran H. Saito 2007 Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles J. Biol. Chem. 282 25123 25130
6. G. Walldius I. Jungner I. Holme A.H. Aastveit W. Kolar E. Steiner 2001 High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2026 2033
7. G. Walldius I. Jungner A.H. Aastveit I. Holme C.D. Furberg A.D. Sniderman 2004 The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk Clin. Chem. Lab. Med. 42 1355 1363
8. S. Yusuf S. Hawken S. Ôunpuu T. Dans A. Avezum F. Lanas 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937 952
9. W.A. van der Steeg S.M. Boekholdt E.A. Stein K. El-Harchaoui E.S.G. Stroes M.S. Sandhu 2007 Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: A case-control analysis in EPIC-Norfolk Ann. Intern. Med. 146 640 648
10. L. Berglund R. Ramakrishnan 2004 Lipoprotein(a): an elusive cardiovascular risk factor Aterioscler. Thromb. Vasc. Biol. 24 2219 2226
11. M. Hartmann C. von Birgelen G.S. Mintz M.G. Stoel H. Eggebrecht H. Wieneke 2006 Relation between lipoprotein (a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries J. Am. Coll. Cardiol. 48 446 452
12. E.M. Antman D.T. Anbe P.W. Armstrong E.R. Bates L.A. Green M. Hand 2004 ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 110 e82 292
13. R.J. Gibbons G.J. Balady J.T. Bricker B.R. Chaitman G.F. Fletcher V.F. Froelicher 2002 ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 40 1531 1540
14. M.D. Cheitlin W.F. Armstrong G.P. Aurigemma G.A. Beller F.Z. Bierman J.L. Davis 2003 ACC/AHA/ASE guideline update for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J. Am. Soc. Echocardiogr. 16 1091 1110
15. S.C. Smith Jr. T.E. Feldman J.W. Hirshfeld Jr. A.K. Jacobs M.J. Kern S.B. King 2006 ACC/AHA/SCAI guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 113 156 175
16. S. Silber P. Albertsson F.F. Aviles P.G. Camici A. Colombo C. Hamm 2005 Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J. 26 804 847
17. S.M. Marcovina J.J. Albers L.O. Henderson W.H. Hannon 1993 International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material Clin. Chem. 39 773 781
18. S.M. Marcovina J.J. Albers H. Kennedy J.V. Mei L.O. Henderson W.H. Hannon 1994 International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material Clin. Chem. 40 586 592
19. S.M. Marcovina J.J. Albers A.M. Scanu H. Kennedy F. Giaculli K. Berg 2000 Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a) Clin. Chem. 46 1956 1967
20. G. Mancia E.A. Rosei R. Cifkova G. DeBacker S. Erdine R. Fagard 2003 European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension J. Hypertens. 21 1011 1053
21. The Expert Committee on the DiagnosisClassification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus 2003 Diabetes Care 26 3160 3167
22. P. Poirier T.D. Giles G.A. Bray Y. Hong Y.S. Stern F.X. Pi-Sunyer 2006 Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss an update of the 1997 American Heart Association Scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism Circulation 113 898 918
23. T. Fawcett 2006 An introduction to ROC analysis Pattern Recognition Letters 27 861 874
24. G. Luc J.M. Bard J. Ferrieres A. Evans P. Amouyel D. Arveiler 2002 Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Arterioscler. Thromb. Vasc. Biol. 22 1155 1161
25. C. Meisinger H. Loewel W. Mraz W. Koenig 2005 Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study Eur. Heart J. 26 271 278
26. T.R. Pedersen O. Faergeman J.J.P. Kastelein A.G. Olsson M.J. Tikkanen I. Holme 2005 The Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial J.A.M.A. 294 2437 2445
27. W.A. van der Steeg I. Holme S.M. Boekholdt M.L. Larsen C. Lindahl E.S. Stroes 2008 High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies J. Am. Coll. Cardiol. 51 634 642
28. S.R. Holmer C. Hengstenberg H.G. M. B. P. M. Kraft S. Kürzinger 2003 Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarctio Circulation 107 696 701
29. G.L. Myers R.H. Christenson M. Cushman C.M. Ballantyne G.R. Cooper S.M. Grundy 2007 National academy of clinical biochemistry laboratory medicine practice guidelines. Emerging biomarkers of cardiovascular disease and stroke Clin. Chim. Lab. Med. 53 552 574
30. G. Luc J.M. Bard D. Arveiler J. Ferrieres A. Evans P. Amouyel 2002 Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study Atherosclerosis 163 377 384
31. A. von Eckardstein H. Schulte P. Cullen G. Assmann 2001 Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk J. Am. Coll. Cardiol. 37 434 439
32. A. Thompson J. Danesh 2006 Associations between apolipoprotein B, apolipoprotein A-I, the apolipoprotein B/A-I ratio and coronary heart disease: a literature-based meta-analysis of prospective studies J. Intern Med. 259 481 492
33. A.D. Sniderman A.C. St Pierre B. Cantin G.R. Dagenais J.P. Despres B. Lamarche 2003 Concordance / discordance between plasma apolipoprotein B levers and the cholesterol indexes of atherosclerotic risk Am. J. Cardiol. 91 1173 1177
34. G. Walldius I. Jungner 2006 The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence J. Intern Med. 259 493 519
35. A.M. Gotto Jr. E. Whitney E.A. Stein D.R. Shapiro M. Clearfield S. Weis 2000 Relation between baseline and on treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation 101 477 484
36. P.J. Barter C.M. Ballantyne R. Carmena M. Castro Cabezas M.J. Chapman P. Couture 2006 ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel J. Intern Med. 259 247 258